glp-1 signaling Glucagon-like peptide 1 (GLP-1) The therapeutic potential of GLP‐1

Description

These studies want to figure out exactly how it all works , which could lead to new advice about what to eat

Funding The report was jointly commissioned and funded by the ADA and EASD

J., Henselmans, M., Helms, E., Aragon, A

J Endocrinol 264(2):e240210 [DOI] [PubMed] [Google Scholar] 83.McIntyre RS, Mansur RB, Rosenblat JD, Rhee TG, Cao B, Teopiz KM, Wong S, Le GH, Ho R, Kwan ATH (2025) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)

In December 2025, the FDA approved the first oral GLP-1 pill for weight management, and compounding pharmacies have introduced oral disintegrating tablet (ODT) formulations that bypass the digestive system entirely